Titre (en)
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Titre (en) » - entrée « syndrome »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
symptoms < syndrome < syndromes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]
Ident.Authors (with country if any)Title
000009 (2020) C B Wu [République populaire de Chine] ; H Y Zhang [République populaire de Chine] ; S H Shao [République populaire de Chine] ; L W Dou [République populaire de Chine] ; Q Y Zhou [République populaire de Chine] ; Y. Liu [République populaire de Chine] ; W B Gao [République populaire de Chine] ; J H Zhu [République populaire de Chine][A report of six TAFRO syndrome: clinical characteristics, diagnosis and treatment analysis].
000020 (2020) Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis]Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report.
000022 (2020) Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie]Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
000054 (2020) Rongda Li [République populaire de Chine] ; Qi Wan [République populaire de Chine] ; Pan Chen [République populaire de Chine] ; Shufen Mao [République populaire de Chine] ; Qiuju Wang [République populaire de Chine] ; Xiaoxin Li [République populaire de Chine] ; Yi Yang [République populaire de Chine] ; Li Dong [République populaire de Chine]Tocilizumab treatment in Felty's syndrome.
000058 (2020) Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon]Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
000074 (2020) Grégoire Ducoux [France] ; Arthur Guerber [France] ; Cécile-Audrey Durel [France] ; Bouchra Asli [France] ; Jehane Fadlallah [France] ; Arnaud Hot [France]Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients
000095 (2020) Chi Zhang [République populaire de Chine] ; Zhao Wu [République populaire de Chine] ; Jia-Wen Li [République populaire de Chine] ; Hong Zhao [République populaire de Chine] ; Gui-Qiang Wang [République populaire de Chine]The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality
000124 (2020) Lanlan Fang ; Yiran Li ; Sijia Wang ; Yuxi Li ; Hsun-Ming Chang ; Yuyin Yi ; Yang Yan ; Avinash Thakur ; Peter C. K. Leung ; Jung-Chien Cheng ; Ying-Pu SunTGF-β1 induces VEGF expression in human granulosa-lutein cells: a potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome
000141 (2020) Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada]Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature.
000150 (2020) Giovanna Garufi [Italie] ; Luisa Carbognin [Italie] ; Armando Orlandi [Italie] ; Giampaolo Tortora [Italie] ; Emilio Bria [Italie]Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence.
000208 (2020) Natalia Maximova [Italie] ; Alessandra Maestro [Italie] ; Davide Zanon [Italie] ; Annalisa Marcuzzi [Italie]Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
000209 (2020) Gonzalo De Luna [France] ; Anoosha Habibi [France] ; Jean François Deux [France] ; Martin Colard [France] ; Anne Laure Pham Hung D'Alexandry D'Orengiani [France] ; Frédéric Schlemmer [France] ; Nizar Joher [France] ; Christian Kassasseya [France] ; Jean Michel Pawlotsky [France] ; Clément Ourghanlian [France] ; Marc Michel [France] ; Armand Mekontso-Dessap [France] ; Pablo Bartolucci [France]Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.
000212 (2020) Nanase Honda [Japon] ; Naoto Yokogawa [Japon] ; Tomohiro Koga ; Yushiro Endo ; Shiro Matsubara [Japon]Protracted Febrile Myalgia Syndrome Treated With Tocilizumab.
000232 (2020) Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie]Pistes urgentes dans le traitement de l’infection par le COVID-19 : cibler l’inflammation en aval pour prévenir un syndrome catastrophique☆
000248 (2020) María Alejandra Marín-Noriega [Colombie] ; Juliana Mu Oz-Ortiz [Colombie] ; Catalina Mosquera [Colombie] ; Alejandra De-La-Torre [Colombie]Ophthalmological treatment of early-onset sarcoidosis/Blau syndrome in a Colombian child: A case report
000266 (2020) Jessica Vandenhaute [Belgique] ; Carine H. Wouters [Belgique] ; Patrick Matthys [Belgique]Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome
000271 (2020) Gabriella Bottari [Italie] ; Pietro Merli [Italie] ; Isabella Guzzo [Italie] ; Francesca Stoppa [Italie] ; Annalisa Ruggeri [Italie] ; Matteo Di Nardo [Italie] ; Francesca Del Bufalo [Italie] ; Federica Galaverna [Italie] ; Cecchetti Corrado [Italie] ; Franco Locatelli [Italie]Multimodal Therapeutic Approach of Cytokine Release Syndrome Developing in a Child Given Chimeric Antigen Receptor-Modified T Cell Infusion
000291 (2020) Yusuf Yazici [États-Unis]Management of Behçet syndrome.
000296 (2020) Mayan Gilboa [Israël] ; Gil Bornstein [Israël] ; Ilan Ben-Zvi [Israël] ; Chagai Grossman [Israël]Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
000299 (2020) Daniel H. Glaser [États-Unis] ; Christina Schutt [États-Unis] ; Kaila Schollaert-Fitch [États-Unis] ; Kathryn Torok [États-Unis]Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties
000351 (2020) Etienne Dufranc [France] ; Arnaud Del Bello [France] ; Julie Belliere [France] ; Nassim Kamar [France] ; Stanislas Faguer [France]IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "syndrome" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "syndrome" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    syndrome
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021